The global Tecentriq market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Tecentriq is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Tecentriq is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Tecentriq is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Tecentriq include Roche. etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for Tecentriq, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Tecentriq, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Tecentriq, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tecentriq sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Tecentriq market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Tecentriq sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roche. etc.
By Company
Roche
Segment by Type
60mg/ml
Other
Segment by Application
Urothelial Carcinoma
Non-Small Cell Lung Cancer (NSCLC)
Triple-Negative Breast Cancer (TNBC)
Small Cell Lung Cancer
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Tecentriq in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Tecentriq manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tecentriq sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Tecentriq Product Introduction
1.2 Market by Type
1.2.1 Global Tecentriq Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 60mg/ml
1.2.3 Other
1.3 Market by Application
1.3.1 Global Tecentriq Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Urothelial Carcinoma
1.3.3 Non-Small Cell Lung Cancer (NSCLC)
1.3.4 Triple-Negative Breast Cancer (TNBC)
1.3.5 Small Cell Lung Cancer
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tecentriq Sales Estimates and Forecasts 2018-2029
2.2 Global Tecentriq Revenue by Region
2.2.1 Global Tecentriq Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Tecentriq Revenue by Region (2018-2023)
2.2.3 Global Tecentriq Revenue by Region (2024-2029)
2.2.4 Global Tecentriq Revenue Market Share by Region (2018-2029)
2.3 Global Tecentriq Sales Estimates and Forecasts 2018-2029
2.4 Global Tecentriq Sales by Region
2.4.1 Global Tecentriq Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Tecentriq Sales by Region (2018-2023)
2.4.3 Global Tecentriq Sales by Region (2024-2029)
2.4.4 Global Tecentriq Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Tecentriq Sales by Manufacturers
3.1.1 Global Tecentriq Sales by Manufacturers (2018-2023)
3.1.2 Global Tecentriq Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tecentriq in 2022
3.2 Global Tecentriq Revenue by Manufacturers
3.2.1 Global Tecentriq Revenue by Manufacturers (2018-2023)
3.2.2 Global Tecentriq Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Tecentriq Revenue in 2022
3.3 Global Key Players of Tecentriq, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Tecentriq Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Tecentriq Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Tecentriq, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Tecentriq, Product Offered and Application
3.8 Global Key Manufacturers of Tecentriq, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Tecentriq Sales by Type
4.1.1 Global Tecentriq Historical Sales by Type (2018-2023)
4.1.2 Global Tecentriq Forecasted Sales by Type (2024-2029)
4.1.3 Global Tecentriq Sales Market Share by Type (2018-2029)
4.2 Global Tecentriq Revenue by Type
4.2.1 Global Tecentriq Historical Revenue by Type (2018-2023)
4.2.2 Global Tecentriq Forecasted Revenue by Type (2024-2029)
4.2.3 Global Tecentriq Revenue Market Share by Type (2018-2029)
4.3 Global Tecentriq Price by Type
4.3.1 Global Tecentriq Price by Type (2018-2023)
4.3.2 Global Tecentriq Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Tecentriq Sales by Application
5.1.1 Global Tecentriq Historical Sales by Application (2018-2023)
5.1.2 Global Tecentriq Forecasted Sales by Application (2024-2029)
5.1.3 Global Tecentriq Sales Market Share by Application (2018-2029)
5.2 Global Tecentriq Revenue by Application
5.2.1 Global Tecentriq Historical Revenue by Application (2018-2023)
5.2.2 Global Tecentriq Forecasted Revenue by Application (2024-2029)
5.2.3 Global Tecentriq Revenue Market Share by Application (2018-2029)
5.3 Global Tecentriq Price by Application
5.3.1 Global Tecentriq Price by Application (2018-2023)
5.3.2 Global Tecentriq Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Tecentriq Market Size by Type
6.1.1 US & Canada Tecentriq Sales by Type (2018-2029)
6.1.2 US & Canada Tecentriq Revenue by Type (2018-2029)
6.2 US & Canada Tecentriq Market Size by Application
6.2.1 US & Canada Tecentriq Sales by Application (2018-2029)
6.2.2 US & Canada Tecentriq Revenue by Application (2018-2029)
6.3 US & Canada Tecentriq Market Size by Country
6.3.1 US & Canada Tecentriq Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Tecentriq Sales by Country (2018-2029)
6.3.3 US & Canada Tecentriq Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Tecentriq Market Size by Type
7.1.1 Europe Tecentriq Sales by Type (2018-2029)
7.1.2 Europe Tecentriq Revenue by Type (2018-2029)
7.2 Europe Tecentriq Market Size by Application
7.2.1 Europe Tecentriq Sales by Application (2018-2029)
7.2.2 Europe Tecentriq Revenue by Application (2018-2029)
7.3 Europe Tecentriq Market Size by Country
7.3.1 Europe Tecentriq Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Tecentriq Sales by Country (2018-2029)
7.3.3 Europe Tecentriq Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Tecentriq Market Size
8.1.1 China Tecentriq Sales (2018-2029)
8.1.2 China Tecentriq Revenue (2018-2029)
8.2 China Tecentriq Market Size by Application
8.2.1 China Tecentriq Sales by Application (2018-2029)
8.2.2 China Tecentriq Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Tecentriq Market Size by Type
9.1.1 Asia Tecentriq Sales by Type (2018-2029)
9.1.2 Asia Tecentriq Revenue by Type (2018-2029)
9.2 Asia Tecentriq Market Size by Application
9.2.1 Asia Tecentriq Sales by Application (2018-2029)
9.2.2 Asia Tecentriq Revenue by Application (2018-2029)
9.3 Asia Tecentriq Sales by Region
9.3.1 Asia Tecentriq Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Tecentriq Revenue by Region (2018-2029)
9.3.3 Asia Tecentriq Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Tecentriq Market Size by Type
10.1.1 Middle East, Africa and Latin America Tecentriq Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Tecentriq Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Tecentriq Market Size by Application
10.2.1 Middle East, Africa and Latin America Tecentriq Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Tecentriq Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Tecentriq Sales by Country
10.3.1 Middle East, Africa and Latin America Tecentriq Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Tecentriq Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Tecentriq Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Overview
11.1.3 Roche Tecentriq Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Roche Tecentriq Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Roche Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tecentriq Industry Chain Analysis
12.2 Tecentriq Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tecentriq Production Mode & Process
12.4 Tecentriq Sales and Marketing
12.4.1 Tecentriq Sales Channels
12.4.2 Tecentriq Distributors
12.5 Tecentriq Customers
13 Market Dynamics
13.1 Tecentriq Industry Trends
13.2 Tecentriq Market Drivers
13.3 Tecentriq Market Challenges
13.4 Tecentriq Market Restraints
14 Key Findings in The Global Tecentriq Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Roche
*If Applicable.